EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preclinical Safety and Immunogenicity Characterization of Emulsivant 70: A Promising Candidate Adjuvant for Emulsified Veterinary Vaccines

Caroline Dohanik iD, Leandro Gonzaga de Oliveira iD, Roberta Ondei iD, Dennis Christensen iD, Diego Dos Santos Ferreira iD, Lucas Antônio Miranda Ferreira iD, Ricardo Tostes Gazzinelli iD, Ana Paula Fernandes iD, Gisele Assis Castro Goulart iD

Journal of Immunology Research · 2026-01 · 2026 (1)

DOI: 10.1155/jimr/7245322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunology Research, online erschienen am 06.11.2026. Verfasst von Caroline Dohanik und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, 31270-901, Minas Gerais, Brazil, uf…. Hauptthemen laut MEDLINE: Adjuvants, Immunologic, Adjuvants, Vaccine, Influenza Vaccines, Orthomyxoviridae Infections. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adjuvants are usually a fundamental part of a vaccine formulation due to their ability to increase immunogenicity, but their safety and efficacy must be established in preclinical studies. In this sense, we evaluated Emulsivant 70, a new ready‐to‐use adjuvant based on water‐in‐oil (W/O) emulsion for veterinary vaccines. Its performance was compared with the commercial adjuvant Montanide ISA 70 in mice immunized with tetanus toxoid (TT) and inactivated influenza PR8. No substantial changes in renal or hepatic biochemical markers (urea, creatinine, alanine aminotransferase [ALT], and aspartate aminotransferase [AST]) were observed for any formulation. Emulsivant 70 induced lower reactogenicity at the injection site than Montanide ISA 70. Both adjuvants enhanced IgG and IgG1 responses, but Emulsivant 70 promoted a faster increase in total IgG for both antigens. IFN‐γ levels increased similarly across adjuvanted groups. Following the influenza A challenge, all PR8‐immunized were fully protected. Overall, this study provides the first evidence that Emulsivant 70 is a safe adjuvant that elicits less local reactivity and achieves immunogenicity comparable to Montanide ISA 70, while inducing a faster humoral response. These findings support Emulsivant 70 as a promising alternative for the development of veterinary vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adjuvants, ImmunologicAdjuvants, VaccineInfluenza VaccinesOrthomyxoviridae InfectionsAnimalsMiceImmunoglobulin GFemaleEmulsionsAntibodies, ViralOleic AcidsMannitolTetanus ToxoidImmunizationImmunogenicity, Vaccine

Stichwörter der Autor:innen

Emulsivant 70Montanide ISA 70adjuvantseffectivenesssafety

Substanzen

Adjuvants, ImmunologicImmunoglobulin GAdjuvants, VaccineEmulsionsInfluenza VaccinesAntibodies, ViralOleic AcidsMannitolTetanus Toxoid

Autor:innen und Institutionen

  • Department of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, 31270-901, Minas Gerais, Brazil, ufmg.br.
  • Detechta, BH-TEC, Belo Horizonte, 31310-260, Minas Gerais, Brazil.
  • Croda do Brasil, Rua Croda 580, Campinas, 13054-710, São Paulo, Brazil.
  • Croda Pharma, Vaccine Adjuvant Systems R&D, Diplomvej 381, Lyngby, DK-2800, Denmark.
  • Vaccine Technology Center of the Federal University of Minas Gerais, Belo Horizonte, 31310-260, Minas Gerais, Brazil.
  • Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, 31270-901, Minas Gerais, Brazil, ufmg.br.

ORCID-Profile: Caroline Dohanik, Leandro Gonzaga de Oliveira, Roberta Ondei, Dennis Christensen, Diego Dos Santos Ferreira, Lucas Antônio Miranda Ferreira, Ricardo Tostes Gazzinelli, Ana Paula Fernandes, Gisele Assis Castro Goulart

Förderung

  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Croda

Zitieren

APA

Dohanik, C., de Oliveira, L. G., Ondei, R., Christensen, D., Dos Santos Ferreira, D., Ferreira, L. A. M., Gazzinelli, R. T., Fernandes, A. P., & Goulart, G. A. C. (2026). Preclinical Safety and Immunogenicity Characterization of Emulsivant 70: A Promising Candidate Adjuvant for Emulsified Veterinary Vaccines. Journal of Immunology Research, 2026(1). https://doi.org/10.1155/jimr/7245322

Vancouver

Dohanik C, de Oliveira LG, Ondei R, Christensen D, Dos Santos Ferreira D, Ferreira LAM, et al. Preclinical Safety and Immunogenicity Characterization of Emulsivant 70: A Promising Candidate Adjuvant for Emulsified Veterinary Vaccines. Journal of Immunology Research. 2026;2026(1). doi:10.1155/jimr/7245322

BibTeX
@article{Dohanik2026,
  author = {Dohanik, Caroline and de Oliveira, Leandro Gonzaga and Ondei, Roberta and Christensen, Dennis and Dos Santos Ferreira, Diego and Ferreira, Lucas Antônio Miranda and Gazzinelli, Ricardo Tostes and Fernandes, Ana Paula and Goulart, Gisele Assis Castro},
  title = {Preclinical Safety and Immunogenicity Characterization of Emulsivant 70: A Promising Candidate Adjuvant for Emulsified Veterinary Vaccines},
  journal = {Journal of Immunology Research},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jimr/7245322}
}
Kostenlos starten →